Allergenic Products Advisory Committee; Cancellation, 53257 [2018-22942]
Download as PDF
<![CDATA[
53257
Federal Register / Vol. 83, No. 204 / Monday, October 22, 2018 / Notices
gear that may not be protective against
all hazards is being used by fire fighters.
Intuitively, the use conditions to
which turnout gear would be exposed to
when used by a large or medium
metropolitan fire department would be
very different than those of a smaller
department. However, the absence of
scientific data to link performance to
use conditions (e.g., number and type of
washings, number of fire-related calls)
provides a barrier to transitioning to an
alternative approach to retirement.
This study will obtain a statistically
meaningful sample of turnout gear from
three fire departments. The use
conditions for the sampled turnout gear
will be determined, and the gear will be
subjected to established performance
requirements. For each set of gear, its
performance will be directly linked to
its use condition history. This combined
lab and field data will help determine
if there is a relationship between
turnout gear use conditions and the
ability for turnout gear to effectively
protect the user.
The use conditions for each set of
sampled gear will be determined by:
(1) Reviewing fire department records,
practices, and policies;
(2) surveying the fire fighters assigned
to each set of sampled gear to obtain
one-month of retrospective information
about the use conditions to which it was
likely exposed; and
(3) a 6-month prospective data
collection where the fire fighters
assigned to each set of sampled gear
provide information about their shiftspecific exposures.
The estimated annualized Burden
Hours for this information collection is
1,050. There is no cost to respondents
other than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Individual Fire Fighter .............
Turnout Gear Safety Survey—Retrospective Exposures for
past month.
Turnout Gear Safety Survey—Prospective Exposures for six
months.
Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.
prompts to the desired center or product
area. Please call the Information Line for
up-to-date information on this meeting.
[FR Doc. 2018–22939 Filed 10–19–18; 8:45 am]
Dated: October 16, 2018.
Leslie Kux,
Associate Commissioner for Policy.
BILLING CODE 4163–18–P
[FR Doc. 2018–22942 Filed 10–19–18; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
Food and Drug Administration
[Docket No. FDA–2018–N–3305]
[Docket No. FDA–2018–N–3728]
Allergenic Products Advisory
Committee; Cancellation
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The meeting of the Allergenic
Products Advisory Committee
scheduled for November 7, 2018, is
cancelled. This meeting was announced
in the Federal Register of September 26,
2018.
FOR FURTHER INFORMATION CONTACT:
Serina Hunter-Thomas, Center for
Biologics Evaluation and Research,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 71, Rm.
6338, Silver Spring, MD 20993–0002,
240–402–5771, serina.hunter-thomas@
fda.hhs.gov, or FDA Advisory
Committee Information Line, 1–800–
741–8138 (301–443–0572 in the
Washington, DC area), and follow the
daltland on DSKBBV9HB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:12 Oct 19, 2018
Jkt 247001
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Collection of
Conflict of Interest Information for
Participation in Food and Drug
Administration Non-Employee
Fellowship and Traineeship Programs
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Average
burden per
response
(in hours)
100
1
30/60
100
60
10/60
to allow 60 days for public comment in
response to the notice. This notice
solicits comments on the ‘‘Collection of
Conflict of Interest Information for
Participation in FDA Non-Employee
Fellowship and Traineeship Programs.’’
DATES: Submit either electronic or
written comments on the collection of
information by December 21, 2018.
ADDRESSES: You may submit comments
as follows. Please note that late,
untimely filed comments will not be
considered. Electronic comments must
be submitted on or before December 21,
2018]. The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of December 21, 2018.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are postmarked or the delivery
service acceptance receipt is on or
before that date.
Electronic Submissions
Notice.
The Food and Drug
Administration (FDA or Agency) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
SUMMARY:
PO 00000
Number of
responses per
respondent
Frm 00052
Fmt 4703
Sfmt 4703
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
E:\FR\FM\22OCN1.SGM
22OCN1
]]>Agencies
[Federal Register Volume 83, Number 204 (Monday, October 22, 2018)]
[Notices]
[Page 53257]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-22942]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2018-N-3305]
Allergenic Products Advisory Committee; Cancellation
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The meeting of the Allergenic Products Advisory Committee
scheduled for November 7, 2018, is cancelled. This meeting was
announced in the Federal Register of September 26, 2018.
FOR FURTHER INFORMATION CONTACT: Serina Hunter-Thomas, Center for
Biologics Evaluation and Research, Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 71, Rm. 6338, Silver Spring, MD 20993-0002,
240-402-5771, [email protected], or FDA Advisory
Committee Information Line, 1-800-741-8138 (301-443-0572 in the
Washington, DC area), and follow the prompts to the desired center or
product area. Please call the Information Line for up-to-date
information on this meeting.
Dated: October 16, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-22942 Filed 10-19-18; 8:45 am]
BILLING CODE 4164-01-P
